// App-Quantinova.ai

: ERCC6L2 in Early-Onset Adult Myelodysplastic Syndrome without Pre-Existing Disorder

Researchers

Presenter

  • Salvador Carrillo-Tornel

Principal Investigators

  • Ana Yeguas Bermejo

  • Helena Pomares

  • Alessandro Liquori

  • Teresa Gonzalez

  • Teresa Bernal del Castillo

  • Marta Santiago

  • Félix López Cadenas

  • BERNARDO LOPEZ ANDRADE

  • Raul Teruel Montoya

  • Esperanza Such

  • Francisca Maria Hernandez

  • Blanca Xicoy

  • Montserrat Arnan Sangerman

  • Francesc Sole

  • Jose Cervera

  • Maria Diez-Campelo

  • Andres Jerez

Medical Centers

  • Hospital Universitario Central Asturias, Oviedo, Spain

  • Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, Spain

  • Josep Carreras Leukemia Research Institute (IJC), ICO-Hospital GermansTrias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

  • Molecular Genetics in Oncohematology, Institute of Biomedical Research of Salamanca (IBSAL) - Cancer Research Center of Salamanca (USAL-CSIC), Salamanca, Spain

  • Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB-CRH, MURCIA, Spain

  • Servicio de Hematología. Hospital La Fe, Valencia, Spain, Valencia, Spain

  • Hospital Virgen de las Nieves, Granada, Salobreña, Spain

  • Hospital Morales Meseguer,CRH-IMIB, Murcia, MURCIA, Spain

  • Clinical Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain, L'Hospitalet de Llobregat, Barcelona, Spain

  • Hematology Department., Hospital Universitario y Politécnico La Fe, Valencia, Spain

  • Hematology Department. Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, L'Hospitalet de Llobregat. Barcelona, Spain

  • Hematology Department, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain

  • Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain

  • Servicio de Hematología y Oncología Médica. H.U. Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB-Arrixaca, Murcia, Spain

  • Hospital Universitario y Politecnico La Fe, CIBERONC, Valencia, Valencia, Spain

  • Department of Hematology and Genetics Unit, Hospital Universitario La Fe, Valencia, Spain

  • Hematology Department, Son Espases University Hospital, IdISBa, Palma Mallorca, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Thrombocytopenia

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved